Agios Pharma (AGIO) Reports Results from Phase 3 ACTIVATE-KidsT Study of Mitapivat
Go back to Agios Pharma (AGIO) Reports Results from Phase 3 ACTIVATE-KidsT Study of Mitapivat| AGIOS PHARM (NASDAQ: AGIO) | Delayed: 33.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.07 | 52 Week High | $71.49 | |||
| Open | $33.07 | 52 Week Low | $33.50 | |||
| Day High | $33.07 | P/E | N/A | |||
| Day Low | $33.07 | EPS | $-1.18 | |||
| Volume | 20 | |||||
